The University of Chicago Header Logo

Atman Shah

Concepts (413)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cardiac Catheterization
20
2025
309
5.040
Why?
Septal Occluder Device
18
2026
52
4.380
Why?
Heart-Assist Devices
11
2018
922
2.430
Why?
Shock, Cardiogenic
6
2024
185
2.180
Why?
Platelet Aggregation Inhibitors
3
2025
194
2.140
Why?
Heart Arrest
14
2024
315
2.020
Why?
Foramen Ovale, Patent
3
2025
23
1.900
Why?
Echocardiography, Transesophageal
15
2025
266
1.850
Why?
Aortic Valve Insufficiency
5
2017
133
1.850
Why?
Atrial Appendage
6
2025
47
1.750
Why?
Myocardial Infarction
12
2024
397
1.750
Why?
Cardiopulmonary Resuscitation
10
2024
257
1.720
Why?
Ventricular Fibrillation
10
2016
77
1.650
Why?
Myocardial Ischemia
8
2024
143
1.640
Why?
Aortic Valve
6
2026
259
1.590
Why?
Aortic Valve Stenosis
7
2026
156
1.560
Why?
Ventricular Function, Left
9
2021
540
1.550
Why?
Heart Valve Prosthesis Implantation
7
2023
192
1.550
Why?
Atrial Fibrillation
8
2026
463
1.510
Why?
Extracorporeal Membrane Oxygenation
6
2024
233
1.450
Why?
Absorbable Implants
4
2021
38
1.390
Why?
Treatment Outcome
46
2026
9806
1.370
Why?
Coronary Vessels
8
2024
182
1.360
Why?
Heart Septal Defects, Ventricular
3
2019
68
1.320
Why?
Coronary Angiography
17
2024
239
1.310
Why?
Popliteal Artery
3
2021
32
1.280
Why?
Peripheral Arterial Disease
3
2021
110
1.260
Why?
Angioplasty, Balloon
2
2020
91
1.200
Why?
Heart Failure
9
2021
1508
1.130
Why?
Ischemia
2
2020
263
1.070
Why?
Prosthesis Design
13
2026
310
1.060
Why?
Ultrasonography, Interventional
4
2025
125
1.050
Why?
Coronary Artery Disease
8
2024
391
1.040
Why?
Thrombosis
4
2025
319
1.020
Why?
Percutaneous Coronary Intervention
7
2020
81
1.010
Why?
Angioplasty, Balloon, Coronary
9
2012
66
0.980
Why?
Cardiac Surgical Procedures
6
2024
511
0.970
Why?
Echocardiography, Three-Dimensional
8
2020
339
0.950
Why?
Registries
11
2026
1133
0.920
Why?
Male
69
2026
47475
0.920
Why?
Endothelin-1
3
2011
43
0.890
Why?
Heart Septal Defects, Atrial
1
2025
61
0.890
Why?
Transcatheter Aortic Valve Replacement
3
2026
79
0.880
Why?
Humans
94
2026
98799
0.870
Why?
Practice Guidelines as Topic
5
2019
1116
0.860
Why?
Anticoagulants
3
2025
486
0.840
Why?
Out-of-Hospital Cardiac Arrest
4
2020
109
0.840
Why?
Aged
40
2026
21986
0.830
Why?
Middle Aged
41
2026
29642
0.830
Why?
Stents
5
2024
442
0.800
Why?
Hemodynamics
7
2026
749
0.780
Why?
Hypothermia, Induced
1
2024
95
0.760
Why?
Time Factors
17
2026
5586
0.750
Why?
Retrospective Studies
29
2026
11104
0.740
Why?
Catheterization
5
2017
220
0.730
Why?
Pulmonary Embolism
6
2021
235
0.720
Why?
Female
55
2026
51997
0.710
Why?
Thrombolytic Therapy
5
2021
261
0.670
Why?
Arrhythmias, Cardiac
2
2017
237
0.650
Why?
Endovascular Procedures
2
2017
403
0.630
Why?
Heart Diseases
5
2021
269
0.620
Why?
Risk Assessment
14
2026
2604
0.620
Why?
Secondary Prevention
1
2021
194
0.610
Why?
Electrocardiography
6
2021
528
0.610
Why?
Stroke
5
2026
1163
0.600
Why?
Heart Ventricles
4
2020
664
0.590
Why?
Coronary Artery Bypass
4
2023
234
0.580
Why?
Aged, 80 and over
15
2026
7461
0.540
Why?
Hospital Costs
1
2019
118
0.530
Why?
Acute Coronary Syndrome
1
2018
31
0.530
Why?
Vena Cava, Superior
1
2018
54
0.520
Why?
Mitral Valve
6
2020
229
0.520
Why?
Clinical Protocols
1
2018
156
0.520
Why?
Swine
14
2016
593
0.520
Why?
Coronary Vessel Anomalies
1
2018
43
0.520
Why?
Balloon Occlusion
3
2012
29
0.510
Why?
Prosthesis Failure
2
2017
118
0.510
Why?
Blood Circulation
1
2017
29
0.510
Why?
Prosthesis Implantation
1
2018
134
0.510
Why?
Heart Massage
1
2017
11
0.510
Why?
Arteriovenous Fistula
1
2018
57
0.510
Why?
Venae Cavae
1
2017
12
0.510
Why?
Transposition of Great Vessels
1
2017
24
0.500
Why?
Device Removal
1
2018
170
0.500
Why?
Computed Tomography Angiography
2
2020
192
0.500
Why?
Drug-Eluting Stents
4
2024
33
0.500
Why?
Aminophylline
1
2016
13
0.500
Why?
Heart Septal Defects
1
2016
28
0.490
Why?
Fibrinolytic Agents
3
2021
244
0.480
Why?
Bradycardia
1
2016
52
0.480
Why?
Constriction, Pathologic
1
2017
214
0.470
Why?
Dyspnea
1
2016
91
0.470
Why?
Balloon Valvuloplasty
1
2015
9
0.460
Why?
Organ Dysfunction Scores
1
2016
34
0.460
Why?
Vascular Fistula
1
2015
12
0.450
Why?
Cardiomyopathies
2
2018
316
0.450
Why?
Mitral Valve Insufficiency
5
2020
179
0.450
Why?
Disease Management
1
2018
378
0.450
Why?
Risk Factors
14
2026
6295
0.450
Why?
Fontan Procedure
1
2015
58
0.440
Why?
Surgery, Computer-Assisted
1
2016
121
0.430
Why?
Defibrillators, Implantable
1
2017
193
0.430
Why?
Ventricular Dysfunction, Right
2
2020
161
0.430
Why?
Postoperative Complications
3
2017
2719
0.420
Why?
Ventricular Septum
1
2014
15
0.420
Why?
Heart Injuries
1
2014
23
0.420
Why?
Iatrogenic Disease
1
2014
71
0.420
Why?
Epinephrine
2
2011
91
0.410
Why?
Follow-Up Studies
7
2025
4049
0.400
Why?
Pulmonary Veins
1
2015
119
0.400
Why?
Aneurysm, False
1
2014
52
0.400
Why?
Echocardiography, Doppler, Color
4
2015
75
0.400
Why?
Adenosine
1
2016
291
0.390
Why?
Heart Valve Prosthesis
3
2026
97
0.380
Why?
Aortic Aneurysm, Thoracic
1
2014
102
0.370
Why?
Heart Defects, Congenital
1
2015
370
0.360
Why?
Biomarkers
4
2019
2026
0.350
Why?
Embolization, Therapeutic
1
2015
338
0.350
Why?
Vascular Patency
3
2021
124
0.340
Why?
Tissue Plasminogen Activator
1
2013
180
0.340
Why?
Thymosin
1
2011
6
0.330
Why?
Coronary Aneurysm
1
2011
15
0.330
Why?
Adult
15
2025
29698
0.330
Why?
Polytetrafluoroethylene
1
2011
72
0.330
Why?
Predictive Value of Tests
8
2025
1792
0.320
Why?
Death, Sudden, Cardiac
1
2011
67
0.320
Why?
Electric Countershock
2
2011
77
0.320
Why?
Coronary Disease
2
2012
227
0.310
Why?
Ventricular Pressure
3
2021
41
0.310
Why?
Severity of Illness Index
7
2019
2025
0.300
Why?
Myocarditis
1
2010
61
0.300
Why?
Coronary Thrombosis
2
2017
15
0.300
Why?
Respiratory Insufficiency
1
2012
205
0.300
Why?
Stem Cell Transplantation
1
2011
196
0.300
Why?
Disease Models, Animal
10
2016
2581
0.290
Why?
Obesity, Morbid
1
2012
255
0.290
Why?
Vascular Endothelial Growth Factor A
1
2011
402
0.290
Why?
After-Hours Care
1
2008
8
0.290
Why?
Heart Rate
2
2010
534
0.280
Why?
United States
9
2026
8387
0.270
Why?
Medical Errors
1
2008
93
0.270
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2007
11
0.260
Why?
Fish Oils
1
2007
15
0.260
Why?
Eicosapentaenoic Acid
1
2007
22
0.260
Why?
Coronary Circulation
3
2024
97
0.260
Why?
Vasodilation
1
2007
91
0.260
Why?
Docosahexaenoic Acids
1
2007
35
0.250
Why?
Hypoxia
1
2012
685
0.250
Why?
Circadian Rhythm
1
2008
295
0.240
Why?
Hemorrhage
2
2025
297
0.230
Why?
Quality Assurance, Health Care
1
2007
229
0.230
Why?
Artifacts
1
2007
248
0.220
Why?
Product Surveillance, Postmarketing
1
2025
38
0.220
Why?
Thrombectomy
1
2008
265
0.220
Why?
Endothelium, Vascular
1
2007
440
0.220
Why?
Feasibility Studies
2
2024
818
0.220
Why?
Saphenous Vein
3
2010
61
0.220
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2008
406
0.210
Why?
Polyvinyls
1
2024
32
0.210
Why?
Ultrasonography
4
2015
722
0.210
Why?
Stroke Volume
5
2021
465
0.210
Why?
Diagnosis, Computer-Assisted
1
2007
338
0.210
Why?
Peripheral Vascular Diseases
1
2004
56
0.210
Why?
Dimethyl Sulfoxide
1
2024
54
0.210
Why?
Hyperlipidemias
1
2004
93
0.210
Why?
Intra-Aortic Balloon Pumping
2
2015
101
0.210
Why?
Cost-Benefit Analysis
2
2019
521
0.200
Why?
Administration, Oral
1
2025
677
0.200
Why?
Carotid Arteries
1
2024
133
0.200
Why?
Health Services Accessibility
1
2008
548
0.200
Why?
Intracranial Arteriosclerosis
1
2024
84
0.190
Why?
Recovery of Function
3
2026
373
0.190
Why?
Cysteine
1
2024
151
0.190
Why?
Vascular Diseases
1
2024
119
0.190
Why?
Osteosarcoma
1
2003
156
0.180
Why?
Clinical Competence
1
2008
873
0.180
Why?
Heart Transplantation
2
2023
879
0.180
Why?
Pulmonary Artery
1
2024
342
0.180
Why?
Microcirculation
2
2024
101
0.180
Why?
Antibodies, Monoclonal
4
2013
1422
0.180
Why?
Coronary Restenosis
4
2017
13
0.180
Why?
Tumor Necrosis Factor-alpha
4
2013
712
0.180
Why?
Ulnar Artery
1
2022
8
0.180
Why?
Survival Rate
5
2019
2057
0.180
Why?
Echocardiography
5
2020
788
0.170
Why?
Radial Artery
1
2022
42
0.170
Why?
Aorta
2
2020
277
0.170
Why?
Heart Atria
3
2016
255
0.170
Why?
Hospitals
2
2021
351
0.170
Why?
Cardiovascular Diseases
2
2007
824
0.170
Why?
Bone Neoplasms
1
2003
316
0.170
Why?
Gene Expression Regulation
2
2009
2023
0.160
Why?
Pilot Projects
1
2024
978
0.160
Why?
Everolimus
1
2021
35
0.160
Why?
Acute Disease
3
2021
864
0.160
Why?
Transillumination
1
2020
6
0.160
Why?
Cardiology
1
2021
125
0.160
Why?
Tomography, X-Ray Computed
6
2017
2680
0.160
Why?
Limb Salvage
1
2020
48
0.160
Why?
Prognosis
5
2024
4139
0.150
Why?
Graft Occlusion, Vascular
2
2010
92
0.150
Why?
ST Elevation Myocardial Infarction
1
2020
17
0.150
Why?
Matrix Metalloproteinase 9
2
2011
85
0.150
Why?
Reoperation
2
2013
730
0.150
Why?
Mobile Applications
1
2021
85
0.150
Why?
Animals
15
2016
29045
0.150
Why?
Resuscitation
2
2011
134
0.150
Why?
Ischemic Attack, Transient
1
2021
196
0.150
Why?
Heart
3
2020
527
0.140
Why?
Health Equity
1
2021
117
0.140
Why?
Fluoroscopy
1
2019
139
0.140
Why?
Venous Thrombosis
1
2021
265
0.140
Why?
Reproducibility of Results
6
2018
2799
0.140
Why?
Echocardiography, Doppler, Pulsed
1
2018
14
0.140
Why?
Atrial Function, Left
1
2018
37
0.140
Why?
Quality-Adjusted Life Years
1
2019
170
0.130
Why?
Monocytes
1
2019
219
0.130
Why?
Microvessels
1
2018
70
0.130
Why?
Glomerular Filtration Rate
1
2018
304
0.130
Why?
Arterial Switch Operation
1
2017
5
0.130
Why?
Communication
1
2021
457
0.130
Why?
Recurrence
2
2012
1274
0.130
Why?
Purinergic P1 Receptor Antagonists
1
2016
6
0.130
Why?
Blood Pressure
3
2013
923
0.120
Why?
Echocardiography, Doppler
1
2017
138
0.120
Why?
Renal Veins
1
2017
28
0.120
Why?
Purinergic P2Y Receptor Antagonists
1
2016
12
0.120
Why?
Tumor Necrosis Factors
1
2016
14
0.120
Why?
Foreign-Body Migration
1
2017
32
0.120
Why?
Triage
1
2018
150
0.120
Why?
Databases, Factual
2
2019
1102
0.120
Why?
Bioprosthesis
1
2016
43
0.120
Why?
Decision Support Techniques
1
2018
193
0.120
Why?
Chronic Disease
1
2019
991
0.120
Why?
Vascular Surgical Procedures
1
2018
173
0.120
Why?
Minimally Invasive Surgical Procedures
2
2016
317
0.120
Why?
Ventricular Dysfunction, Left
1
2018
264
0.120
Why?
Equipment Failure
1
2016
120
0.120
Why?
Cannula
1
2016
55
0.120
Why?
Vena Cava Filters
1
2017
92
0.110
Why?
Emergency Service, Hospital
3
2016
630
0.110
Why?
Macrophages
1
2019
641
0.110
Why?
Subclavian Artery
1
2015
43
0.110
Why?
Length of Stay
1
2019
889
0.110
Why?
Prospective Studies
5
2018
4837
0.110
Why?
Fatal Outcome
2
2016
295
0.100
Why?
Random Allocation
4
2020
312
0.100
Why?
Acute Kidney Injury
1
2018
361
0.100
Why?
Hyperthermia, Induced
1
2014
77
0.100
Why?
Comorbidity
2
2015
1037
0.100
Why?
Aortography
1
2014
62
0.100
Why?
California
3
2010
182
0.100
Why?
Contrast Media
1
2018
1014
0.100
Why?
Blood Transfusion, Autologous
1
2013
18
0.100
Why?
Kidney
1
2018
1126
0.100
Why?
Magnetic Resonance Imaging
2
2017
3622
0.100
Why?
Infusions, Parenteral
1
2013
47
0.100
Why?
Amiodarone
1
2013
16
0.100
Why?
Diagnosis, Differential
2
2010
1571
0.100
Why?
Dobutamine
1
2013
38
0.100
Why?
L-Lactate Dehydrogenase
1
2013
71
0.100
Why?
International Normalized Ratio
1
2013
38
0.100
Why?
Pulsatile Flow
1
2013
52
0.090
Why?
Anti-Arrhythmia Agents
1
2013
77
0.090
Why?
Image Interpretation, Computer-Assisted
1
2017
645
0.090
Why?
Software
1
2017
698
0.090
Why?
Survival Analysis
1
2016
1530
0.090
Why?
Pulmonary Wedge Pressure
1
2013
124
0.090
Why?
Exercise Test
1
2013
159
0.090
Why?
Algorithms
2
2017
2005
0.090
Why?
Whole Blood Coagulation Time
1
2012
7
0.090
Why?
Mitral Valve Stenosis
1
2012
27
0.090
Why?
Renal Insufficiency, Chronic
2
2018
271
0.090
Why?
Labetalol
1
2011
6
0.090
Why?
Metoprolol
1
2011
16
0.090
Why?
Patient Care Team
1
2014
318
0.090
Why?
Vascular Resistance
2
2024
99
0.080
Why?
Radiography, Interventional
1
2012
155
0.080
Why?
Adrenergic beta-Antagonists
1
2011
112
0.080
Why?
Regenerative Medicine
1
2011
29
0.080
Why?
Catheter Ablation
1
2015
388
0.080
Why?
Point-of-Care Systems
1
2012
155
0.080
Why?
Immunoglobulin G
1
2013
481
0.080
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
255
0.080
Why?
Catheters
2
2021
109
0.080
Why?
Vasopressins
1
2010
48
0.080
Why?
Creatine Kinase
1
2010
51
0.080
Why?
Hospital Mortality
2
2026
533
0.080
Why?
Randomized Controlled Trials as Topic
1
2015
995
0.080
Why?
Infliximab
4
2013
170
0.080
Why?
Liver Function Tests
1
2010
95
0.080
Why?
Monitoring, Physiologic
1
2012
265
0.080
Why?
Troponin
1
2010
25
0.080
Why?
Proteinuria
1
2010
72
0.080
Why?
Ventricular Remodeling
1
2011
108
0.080
Why?
Lactic Acid
1
2010
95
0.080
Why?
Patient Selection
3
2020
725
0.080
Why?
Coronary Sinus
1
2010
11
0.080
Why?
Myocardium
2
2010
578
0.080
Why?
Critical Illness
1
2012
364
0.070
Why?
Sirolimus
1
2010
181
0.070
Why?
Endothelin-2
1
2008
1
0.070
Why?
Endothelin-3
1
2008
2
0.070
Why?
Electric Stimulation
1
2010
341
0.070
Why?
Ventricular Premature Complexes
1
2008
14
0.070
Why?
Sensitivity and Specificity
2
2017
1946
0.070
Why?
Paclitaxel
1
2010
484
0.070
Why?
Reperfusion Injury
1
2009
148
0.070
Why?
Up-Regulation
1
2011
742
0.070
Why?
Hypertension, Pulmonary
1
2012
386
0.070
Why?
Chicago
1
2013
1520
0.070
Why?
Diastole
2
2018
102
0.070
Why?
Fatigue
1
2008
187
0.070
Why?
Workload
1
2008
131
0.070
Why?
Nitroglycerin
1
2007
24
0.070
Why?
Vitamin E
1
2007
34
0.070
Why?
Personnel Staffing and Scheduling
1
2008
103
0.060
Why?
Brachial Artery
1
2007
37
0.060
Why?
Selection Bias
1
2007
40
0.060
Why?
Single-Blind Method
1
2007
160
0.060
Why?
Drug Combinations
1
2007
202
0.060
Why?
Cell Movement
1
2011
821
0.060
Why?
Guideline Adherence
1
2008
251
0.060
Why?
Anticholesteremic Agents
1
2008
156
0.060
Why?
Dietary Supplements
1
2007
152
0.060
Why?
Granulocyte Colony-Stimulating Factor
1
2006
158
0.060
Why?
Coated Materials, Biocompatible
1
2005
32
0.060
Why?
Observer Variation
1
2007
579
0.060
Why?
Coronary Stenosis
1
2005
31
0.060
Why?
Cytokines
1
2009
890
0.060
Why?
Immunosuppressive Agents
1
2010
1021
0.060
Why?
Metals
1
2005
105
0.050
Why?
Action Potentials
1
2008
612
0.050
Why?
Cell Differentiation
1
2011
1656
0.050
Why?
Health Knowledge, Attitudes, Practice
1
2008
608
0.050
Why?
Caspases
1
2003
151
0.050
Why?
Treatment Failure
1
2024
300
0.050
Why?
Attitude of Health Personnel
1
2008
688
0.050
Why?
Cerebral Angiography
1
2024
282
0.050
Why?
Blood Vessel Prosthesis Implantation
1
2005
249
0.050
Why?
Muscle, Smooth, Vascular
1
2003
234
0.050
Why?
Young Adult
1
2015
7598
0.050
Why?
Spasm
1
2022
17
0.040
Why?
Preoperative Care
2
2015
420
0.040
Why?
Case-Control Studies
2
2018
2017
0.040
Why?
Lower Extremity
1
2021
112
0.040
Why?
Pulmonary Valve
1
2020
33
0.040
Why?
Cardiac Output
1
2020
142
0.040
Why?
Chi-Square Distribution
2
2010
361
0.040
Why?
Organ Size
1
2020
370
0.040
Why?
Tissue Donors
1
2023
581
0.040
Why?
Prevalence
1
2023
1396
0.040
Why?
Protective Factors
1
2018
30
0.040
Why?
Odds Ratio
1
2020
728
0.030
Why?
Proportional Hazards Models
2
2010
925
0.030
Why?
Tricuspid Valve
1
2018
95
0.030
Why?
Antigens, CD
1
2019
482
0.030
Why?
Diffusion of Innovation
1
2017
81
0.030
Why?
Apoptosis
1
2003
1754
0.030
Why?
Equipment Design
1
2018
428
0.030
Why?
Prosthesis Fitting
1
2017
17
0.030
Why?
Anti-Inflammatory Agents
2
2010
362
0.030
Why?
Phlebography
1
2017
74
0.030
Why?
Illinois
1
2018
531
0.030
Why?
Oxygen
1
2021
777
0.030
Why?
Health Status
1
2018
388
0.030
Why?
Quality of Life
1
2004
1904
0.030
Why?
Health Care Surveys
1
2016
282
0.030
Why?
Healthcare Disparities
1
2021
558
0.030
Why?
Clinical Decision-Making
1
2017
306
0.030
Why?
Evidence-Based Medicine
1
2017
483
0.030
Why?
Program Evaluation
1
2016
349
0.030
Why?
Image Enhancement
1
2017
503
0.030
Why?
Ultrafiltration
1
2013
11
0.020
Why?
Random Amplified Polymorphic DNA Technique
1
2013
5
0.020
Why?
Jehovah's Witnesses
1
2013
21
0.020
Why?
Lidocaine
1
2013
62
0.020
Why?
Etanercept
1
2013
37
0.020
Why?
Heart Arrest, Induced
1
2013
30
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2013
85
0.020
Why?
Hemoglobins
1
2013
197
0.020
Why?
Cardiopulmonary Bypass
1
2013
162
0.020
Why?
Vasodilator Agents
1
2013
133
0.020
Why?
Reference Values
1
2013
608
0.020
Why?
Sus scrofa
1
2011
50
0.020
Why?
Confidence Intervals
1
2011
221
0.020
Why?
Statistics, Nonparametric
1
2011
304
0.020
Why?
Adrenergic Antagonists
1
2010
3
0.020
Why?
Practice Patterns, Physicians'
1
2016
669
0.020
Why?
Adolescent
1
2003
10168
0.020
Why?
Interleukin-1beta
1
2010
92
0.020
Why?
Creatinine
1
2010
315
0.020
Why?
Inflammation Mediators
1
2009
165
0.020
Why?
Cardiology Service, Hospital
1
2008
6
0.020
Why?
Models, Animal
1
2009
282
0.020
Why?
Age Factors
1
2013
1976
0.020
Why?
False Positive Reactions
1
2008
214
0.020
Why?
Kaplan-Meier Estimate
1
2010
909
0.020
Why?
Disease-Free Survival
1
2010
1196
0.020
Why?
Inflammation
1
2013
1134
0.020
Why?
Leukocyte Count
1
2006
215
0.010
Why?
Sex Factors
1
2009
1144
0.010
Why?
Dilatation, Pathologic
1
2006
47
0.010
Why?
Collagen
1
2006
313
0.010
Why?
Emergency Medical Services
1
2008
289
0.010
Why?
Analysis of Variance
1
2006
890
0.010
Why?
Amino Acid Chloromethyl Ketones
1
2003
25
0.010
Why?
Caspase Inhibitors
1
2003
32
0.010
Why?
Tunica Intima
1
2003
62
0.010
Why?
Hyperplasia
1
2003
149
0.010
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2006
464
0.010
Why?
Rabbits
1
2003
582
0.010
Why?
Incidence
1
2005
1798
0.010
Why?
Shah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (413)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_